On October 23, 2017, the National Viral Hepatitis Roundtable (NVHR) and the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) released “Hepatitis C: State of Medicaid Access”. The report (http://stateofhepc.org) grades each state Medicaid program, as well as the District of Columbia and Puerto Rico, based on three types of treatment restrictions for hepatitis C: 1) liver disease progression (fibrosis) restrictions, 2) sobriety/substance use requirements, and 3) prescriber limitations.
Sadly, Hawaii got a grade of D+, along more than half of Medicaid programs that received a “D” or an “F”. As a coalition, we recognize that Hawaii's low grade means we have a lot more work to do. Let's move towards a hep C cure for everyone!